AB145869
Reversan, MRP1 and P-glycoprotein inhibitor
Be the first to review this product! Submit a review
|
(1 Publication)
MW 441.53 g/mol, Purity >99%. Selective MRP1 and P-glycoprotein inhibitor. Chemosensitizing agent. Increases the sensitivity of MRP1-overexpressing tumor cells to doxorubicin (ab120629), vincristine (ab120226) and etoposide (ab120227). Shows chemosensitizing, antitumor effects in vivo. .
1 Images
- Chemical Structure
Lab
Chemical Structure - Reversan, MRP1 and P-glycoprotein inhibitor (AB145869)
2D chemical structure image of ab145869, Reversan, MRP1 and P-glycoprotein inhibitor
Properties and storage information
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
The product can be stored for up to 12 months
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
The FEBS journal 286:678-687 PubMed30653821
2019
NOX1/NADPH oxidase regulates the expression of multidrug resistance-associated protein 1 and maintains intracellular glutathione levels.
Applications
Unspecified application
Species
Unspecified reactive species
Xiaopeng Wen,Kazumi Iwata,Keiko Ikuta,Xueqing Zhang,Kai Zhu,Masakazu Ibi,Misaki Matsumoto,Nozomi Asaoka,Junjie Liu,Masato Katsuyama,Chihiro Yabe-Nishimura
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com